IO Biotech, Inc. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
IO Biotech, Inc. reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$57.02 million for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2025-11-14
- IO Biotech, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-09-30 was -$8.38M.
- IO Biotech, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-06-30 was -$26.22M.
- IO Biotech, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-03-31 was -$22.42M.
- IO Biotech, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2024-12-31 was -$31.33M.
- IO Biotech, Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2024 was -$95.49M.
- IO Biotech, Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2023 was -$86.08M.
- IO Biotech, Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2022 was -$71.46M.
- IO Biotech, Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2021 was -$67.88M.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2025-09-30 | -$8.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$34.59M derived: sum of 2 quarters · filed 2025-11-14 | -$57.02M 10-Q · filed 2025-11-14 | -$88.35M derived: sum of 4 quarters · filed 2025-11-14 |
| 2025-06-30 | -$26.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$48.64M 10-Q · filed 2025-08-14 | -$79.97M derived: sum of 3 quarters · filed 2025-08-14 | -$103.99M derived: sum of 4 quarters · filed 2025-11-14 |
| 2025-03-31 | -$22.42M 10-Q · filed 2025-05-14 | -$53.75M derived: sum of 2 quarters · filed 2025-05-14 | -$77.77M derived: sum of 3 quarters · filed 2025-11-14 | -$98.45M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-12-31 | -$31.33M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$55.35M derived: sum of 2 quarters · filed 2025-11-14 | -$76.03M derived: sum of 3 quarters · filed 2025-11-14 | -$95.49M 10-K · filed 2025-03-31 |
| 2024-09-30 | -$24.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$44.70M derived: sum of 2 quarters · filed 2025-11-14 | -$64.16M 10-Q · filed 2025-11-14 | -$90.34M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | -$20.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$40.14M 10-Q · filed 2025-08-14 | -$66.33M derived: sum of 3 quarters · filed 2025-08-14 | -$88.00M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$19.46M 10-Q · filed 2025-05-14 | -$45.64M derived: sum of 2 quarters · filed 2025-05-14 | -$67.32M derived: sum of 3 quarters · filed 2025-05-14 | -$88.50M derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | -$26.18M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$47.86M derived: sum of 2 quarters · filed 2025-03-31 | -$69.04M derived: sum of 3 quarters · filed 2025-03-31 | -$86.08M 10-K · filed 2025-03-31 |
| 2023-09-30 | -$21.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$42.86M derived: sum of 2 quarters · filed 2024-11-12 | -$59.90M 10-Q · filed 2024-11-12 | -$79.97M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$21.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$38.22M 10-Q · filed 2024-08-13 | -$58.29M derived: sum of 3 quarters · filed 2024-08-13 | -$73.98M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | -$17.04M 10-Q · filed 2024-05-14 | -$37.12M derived: sum of 2 quarters · filed 2024-05-14 | -$52.80M derived: sum of 3 quarters · filed 2024-05-14 | -$71.30M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | -$20.07M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | -$35.76M derived: sum of 2 quarters · filed 2024-03-05 | -$54.25M derived: sum of 3 quarters · filed 2024-03-05 | -$71.46M 10-K · filed 2024-03-05 |
| 2022-09-30 | -$15.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$34.18M derived: sum of 2 quarters · filed 2023-11-13 | -$51.39M 10-Q · filed 2023-11-13 | -$72.70M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$18.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | -$35.70M 10-Q · filed 2023-08-11 | -$57.01M derived: sum of 3 quarters · filed 2023-08-11 | -$61.47M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | -$17.20M 10-Q · filed 2023-05-11 | -$38.51M derived: sum of 2 quarters · filed 2023-05-11 | -$42.98M derived: sum of 3 quarters · filed 2023-05-11 | -$81.33M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$21.31M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | -$25.77M derived: sum of 2 quarters · filed 2023-03-14 | -$64.13M derived: sum of 3 quarters · filed 2023-03-14 | -$67.88M 10-K · filed 2023-03-14 |
| 2021-09-30 | -$4.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$42.82M derived: sum of 2 quarters · filed 2022-11-09 | -$46.57M 10-Q · filed 2022-11-09 | -$49.12M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | -$38.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$42.11M 10-Q · filed 2022-08-11 | -$44.66M derived: sum of 3 quarters · filed 2022-08-11 | |
| 2021-03-31 | -$3.75M 10-Q · filed 2022-05-16 | -$6.30M derived: sum of 2 quarters · filed 2022-05-16 | ||
| 2020-12-31 | -$2.55M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | -$12.04M 10-K · filed 2022-03-31 | ||
| 2020-09-30 | -$9.49M 10-Q · filed 2021-12-17 |